2017. Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK). ADMET and DMPK. 5, 1 (Mar. 2017), 1–8. DOI:https://doi.org/10.5599/admet.5.1.352.